Physician profile
Brian Kim
NPI 1558899716
$61,465.61
in general payments reported to CMS, 2019-2025
19 companies · $890 in 2025
The $890 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $47K · 2022: $6,691 · 2023: $3,961 · 2024: $2,694 · 2025: $890.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,758 · Travel and Lodging: $1,741 · Entertainment: $45.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,758.08 |
| Travel and Lodging | $1,741.36 |
| Entertainment | $45.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $20,259.59 | 2021-2025 | Inceptiv |
| Boston Scientific Corporation | $18,763.66 | 2021-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Abbott Laboratories | $13,236.41 | 2021-2025 | Proclaim, Eterna, Axium |
| Nevro Corp. | $3,690.92 | 2021-2024 | Senza |
| Saluda Medical Americas, INC. | $2,575.33 | 2023-2025 | Evoke Scs, Evoke |
| Spinal Simplicity, LLC | $727.01 | 2021-2024 | Ha Minuteman G3-R |
| Painteq LLC | $452.17 | 2022-2023 | Painteq |
| Nalu Medical, INC. | $319.50 | 2021-2023 | Nalu Neurostimulation System |
| Foundation Fusion Solutions, LLC | $315.86 | 2024-2025 | |
| Spr Therapeutics, INC | $303.65 | 2021-2025 | Sprint Pns System |
| Mml US, INC. | $285.43 | 2021-2025 | Reactiv8 |
| Globus Medical, INC. | $277.59 | 2025 | Senza |
| Relievant Medsystems, INC. | $108.41 | 2022 | |
| Biotronik Nro, INC. | $45.91 | 2025 | Prospera |
| Novo Nordisk INC | $43.18 | 2022-2024 | Ozempic, Rybelsus |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $17.89 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $16.07 | 2025 | |
| Abbvie INC. | $14.64 | 2023 | |
| Glaxosmithkline, LLC. | $12.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.